Considering the vascular protective effects associated with GPER activation (Gros et al., 2013), and that aldosterone has been shown to activate GPER (Gros et al., 2011) we hypothesized that the beneficial effects mediated by vascular GPER activation are decreased in diabetes. The gene discussed is GPER1; the disease is diabetes mellitus.